PLX.TA - Protalix BioTherapeutics, Inc.

Tel Aviv - Tel Aviv Delayed Price. Currency in ILS
Currency in ILS

Valuation Measures

Market Cap (intraday) 5218.67M
Enterprise Value 3241.09M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)5.76
Price/Book (mrq)N/A
Enterprise Value/Revenue 36.35
Enterprise Value/EBITDA 6-13.36

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin -69.75%
Operating Margin (ttm)-51.87%

Management Effectiveness

Return on Assets (ttm)-19.56%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)37.97M
Revenue Per Share (ttm)0.26
Quarterly Revenue Growth (yoy)55.50%
Gross Profit (ttm)24.94M
EBITDA -18.05M
Net Income Avi to Common (ttm)-26.48M
Diluted EPS (ttm)-0.18
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)30.36M
Total Cash Per Share (mrq)0.2
Total Debt (mrq)59.72M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.75
Book Value Per Share (mrq)-0.40

Cash Flow Statement

Operating Cash Flow (ttm)-5.61M
Levered Free Cash Flow (ttm)-271.62k

Trading Information

Stock Price History

Beta (3Y Monthly) 2.38
52-Week Change 3-9.26%
S&P500 52-Week Change 34.92%
52 Week High 3276.70
52 Week Low 3108.00
50-Day Moving Average 3149.94
200-Day Moving Average 3155.87

Share Statistics

Avg Vol (3 month) 3111.79k
Avg Vol (10 day) 3118.95k
Shares Outstanding 5148.38M
Float 144.79M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A